A neonate may develop hypoglycemia during or after transfusion of a blood product.


Implicated products:

(1) packed red blood cells

(2) fresh frozen plasma (FFP)


Risk factors:

(1) premature infant

(2) only 1 peripheral vascular line available (so dextrose cannot be infused)

(3) use of a blood product anticoagulant/additive low in dextrose

(4) history of recent hypoglycemia


The blood glucose of a neonate should be monitored periodically (every 30 or 60 minutes) following blood product transfusion in order to detect any hypoglycemia.


To read more or access our algorithms and calculators, please log in or register.